Michael Bavaro - Feb 28, 2025 Form 4 Insider Report for Option Care Health, Inc. (OPCH)

Role
Chief Human Resources Officer
Signature
/s/ Sarah Kim, attorney-in-fact for Mr. Bavaro
Stock symbol
OPCH
Transactions as of
Feb 28, 2025
Transactions value $
-$656,060
Form type
4
Date filed
3/3/2025, 05:52 PM
Previous filing
Feb 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPCH Common Stock Options Exercise $23.3K +1.23K +2% $18.97 62.5K Feb 28, 2025 Direct
transaction OPCH Common Stock Options Exercise $231K +8.97K +14.37% $25.75 71.4K Feb 28, 2025 Direct
transaction OPCH Common Stock Options Exercise $51.6K +2.15K +3.01% $23.96 73.6K Feb 28, 2025 Direct
transaction OPCH Common Stock Options Exercise $68.9K +2.39K +3.24% $28.86 76K Feb 28, 2025 Direct
transaction OPCH Common Stock Sale -$1.03M -31K -40.8% $33.26 45K Feb 28, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -1.23K -100% $0.00 0 Feb 28, 2025 Common Stock 1.23K $18.97 Direct F2
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -8.97K -100% $0.00 0 Feb 28, 2025 Common Stock 8.97K $25.75 Direct F2
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -2.15K -50% $0.00 2.15K Feb 28, 2025 Common Stock 2.15K $23.96 Direct F3
transaction OPCH Employee Stock Option (right to buy) Options Exercise $0 -2.39K -33.33% $0.00 4.77K Feb 28, 2025 Common Stock 2.39K $28.86 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 30,996 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 28, 2025 with sale prices ranging from $33.25 to $33.285 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Fully vested.
F3 Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026.
F4 Stock options that vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date.